Fulgent Genetics reported a quarterly loss of $0.36 per share, missing the Zacks Consensus Estimate for a $0.19 loss by $0.17 per share. The result also deteriorated from earnings of $0.04 per share in the same quarter last year, indicating weaker profitability. The update is likely to pressure shares, though it is a single-company earnings miss rather than sector-wide news.
Fulgent Genetics reported a quarterly loss of $0.36 per share, missing the Zacks Consensus Estimate for a $0.19 loss by $0.17 per share. The result also deteriorated from earnings of $0.04 per share in the same quarter last year, indicating weaker profitability. The update is likely to pressure shares, though it is a single-company earnings miss rather than sector-wide news.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
moderately negative
Sentiment Score
-0.42
Ticker Sentiment
